prolidase deficiency |
Disease ID | 239 |
---|---|
Disease | prolidase deficiency |
Definition | Rare autosomal recessive disorder of metabolism due to mutations in the prolidase gene. It is characterized by recurrent lower extremity skin ulcers, recurrent infections, and FACIES, often with INTELLECTUAL DISABILITY. |
Synonym | deficiencies, imidodipeptidase deficiencies, prolidase deficiency of imidodipeptidase deficiency of imidodipeptidase (disorder) deficiency of prolidase deficiency of prolidase (disorder) deficiency of proline dipeptidase deficiency of proline dipeptidase (disorder) deficiency of proline dipeptidase (disorder) [ambiguous] deficiency, imidodipeptidase deficiency, prolidase hyperimidodipeptiduria hyperimidodipeptiduria due to proline dipeptidase deficiency hyperimidodipeptiduria due to proline dipeptidase deficiency (disorder) hyperimidodipeptidurias imidodipeptidase deficiencies imidodipeptidase deficiency iminodipeptiduria prolidase deficiencies prolidase deficiency [disease/finding] prolidase deficiency with hyperimidodipeptiduria proline dipeptidase deficiency proline dipeptidase deficiency (disorder) |
Orphanet | |
OMIM | |
UMLS | C0268532 |
MeSH | |
SNOMED-CT | |
Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:2) |
Curated Gene | Entrez_id | Symbol | Resource(Total Genes:1) |
Inferring Gene | (Waiting for update.) |
Text Mined Gene | (Waiting for update.) |
Locus | Symbol | Locus(Total Locus:1) PEPD | 19q13.11 |
Disease ID | 239 |
---|---|
Disease | prolidase deficiency |
Integrated Phenotype | HPO | Name(Total Integrated Phenotypes:60) HP:0002211 | White forelock HP:0000670 | Carious teeth HP:0002240 | Enlarged liver HP:0006532 | Pneumonia, recurrent episodes HP:0000520 | Proptosis HP:0003196 | Short nose HP:0002715 | Abnormality of the immune system HP:0000365 | Hearing impairment HP:0001166 | Arachnodactyly HP:0000444 | Polly beak nasal deformity HP:0000316 | Increased distance between eye sockets HP:0006579 | Neonatal jaundice HP:0005280 | Depressed nasal bridge HP:0012786 | Recurrent cystitis HP:0002099 | Asthma HP:0002205 | Recurrent respiratory infections HP:0010783 | Erythema HP:0000963 | Thin skin HP:0000967 | Petechiae HP:0007598 | Bilateral single transverse palmar creases HP:0000347 | Micrognathia HP:0001939 | Laboratory abnormality HP:0000316 | Hypertelorism HP:0200034 | Papule HP:0200042 | Skin ulcer HP:0001903 | Anemia HP:0007473 | Crusting erythematous dermatitis HP:0000982 | Palmoplantar keratoderma HP:0007489 | Telangiectases, random body distribution HP:0000962 | Hyperkeratosis HP:0001999 | Facial dysmorphism HP:0008065 | Aplasia/Hypoplasia of the skin HP:0001263 | Developmental retardation HP:0000457 | Depressed nasal ridge HP:0000294 | Low anterior hairline HP:0005280 | Flat, nasal bridge HP:0003272 | Abnormality of the hip bone HP:0001999 | Abnormal facial shape HP:0002230 | Generalized hirsutism HP:0000370 | Abnormality of the middle ear HP:0002240 | Hepatomegaly HP:0002725 | Systemic lupus erythematosus HP:0002857 | Genu valgum HP:0007703 | Abnormality of retinal pigmentation HP:0001873 | Low platelet count HP:0001249 | Intellectual disability HP:0000520 | Anterior bulging of the globe of eye HP:0002162 | Low posterior hair line HP:0001744 | Splenomegaly HP:0006528 | Chronic lung disease HP:0000505 | Visual impairment HP:0000958 | Dry skin HP:0000992 | Cutaneous photosensitivity HP:0001007 | Hirsutism HP:0000989 | Pruritus HP:0004349 | Reduced bone mineral density HP:0011220 | Prominent forehead HP:0000508 | Drooping upper eyelid HP:0001231 | Abnormality of the fingernails HP:0010669 | Cheekbone underdevelopment |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:1) |
Disease ID | 239 |
---|---|
Disease | prolidase deficiency |
Manually Symptom | UMLS | Name(Total Manually Symptoms:3) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
Text Mining Genotype(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
All Snps(Total Genotypes:12) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs121917721 | NA | 5184 | PEPD | umls:C0268532 | CLINVAR | NA | 0.481900093 | NA | PEPD | 19 | 33401862 | C | T |
rs121917722 | NA | 5184 | PEPD | umls:C0268532 | CLINVAR | NA | 0.481900093 | NA | PEPD | 19 | 33464060 | C | T |
rs121917723 | NA | 5184 | PEPD | umls:C0268532 | CLINVAR | NA | 0.481900093 | NA | PEPD | 19 | 33401855 | C | T |
rs121917724 | NA | 5184 | PEPD | umls:C0268532 | CLINVAR | NA | 0.481900093 | NA | PEPD | 19 | 33387892 | C | T |
rs121917725 | NA | 5184 | PEPD | umls:C0268532 | CLINVAR | NA | 0.481900093 | NA | PEPD | 19 | 33411697 | G | C,A |
rs267606943 | NA | 5184 | PEPD | umls:C0268532 | CLINVAR | NA | 0.481900093 | NA | PEPD | 19 | 33464006 | G | A |
rs267606944 | NA | 5184 | PEPD | umls:C0268532 | CLINVAR | NA | 0.481900093 | NA | PEPD | 19 | 33388000 | C | T |
rs747700126 | NA | 5184 | PEPD | umls:C0268532 | CLINVAR | NA | 0.481900093 | NA | PEPD | 19 | 33463032 | C | A,G |
rs757386104 | NA | 5184 | PEPD | umls:C0268532 | CLINVAR | NA | 0.481900093 | NA | PEPD | 19 | 33387465 | TCC | - |
rs794728007 | NA | 5184 | PEPD | umls:C0268532 | CLINVAR | NA | 0.481900093 | NA | PEPD | 19 | 33413622 | GTA | - |
rs794728008 | NA | 5184 | PEPD | umls:C0268532 | CLINVAR | NA | 0.481900093 | NA | PEPD | 19 | 33463987 | - | TCACGGTGGGCCT |
rs797045185 | NA | 5184 | PEPD | umls:C0268532 | CLINVAR | NA | 0.481900093 | NA | PEPD | 19 | 33391344 | A | C |
GWASdb Annotation(Total Genotypes:21) | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chr | Pos | SNP_Id | RefGene | EnsemblGene | ENCODE_Factor | ENCODE_TFBS | Chromosome_interaction | GTEx_eQTL | SNP_TFBS_affinity_GWAS3D | SNP_miRNA_target_affinity_PolymiRTS | SNP_splicing_effect_Skippy | SNP_splicing_effect_MutPred_Splice | SNP_ns_protein_effect_dbNSFP | SNP_syn_effect_Silva | SNP_phosphorylation_effect_PhosSNP | PhastCons_score | PhyloP_score | GERP++_RS | Segway_state | Ancestral_allele | ESP_AF | ESP_AFR | ESP_AFR | ESP_EUR | TG_ASN | TG_AMR | TG_AFR | TG_EUR | Type | Consequence | bStatistic | EncH3K27Ac | EncH3K4Me1 | EncH3K4Me3 | EncNucleo | OMIM | Clinvar |
19 | 33886354 | rs7258031 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | NA | NA | chr19,33880001,33890000,chr17,80930001,80940000,30,Hi-C | chr19,33880001,33890000,chr19,30670001,30680000,5,Hi-C | chr19,33880001,33890000,chr19,34260001,34270000,10,Hi-C | chr19,33880001,33890000,chr19,16060001,16070000,6,Hi-C | NA | Asg1-DBD-primary,1.3817 | Met32-primary,1.5163 | Mig2-primary,2.5412 | Mig3-primary,2.8432 | Rpn4-primary,2.4273 | NA | NA | NA | NA | NA | NA | 0.004 | -0.942 | -3.86 | TF0 | C | NA | NA | NA | NA | NA | NA |
19 | 33889000 | rs889140 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | DRM | TFP.CTCF | MCV-20 | NA | chr19,33880001,33890000,chr17,80930001,80940000,30,Hi-C | chr19,33880001,33890000,chr19,30670001,30680000,5,Hi-C | chr19,33880001,33890000,chr19,34260001,34270000,10,Hi-C | chr19,33880001,33890000,chr19,16060001,16070000,6,Hi-C | NA | LM209,1.789 | LM221,7.8333 | Pax5,2.0963 | dl_1,2.27 | Pax4,1.3523 | NA | NA | NA | NA | NA | NA | 0.000 | -1.017 | -3.05 | C1 | A | NA | NA | NA | 0.620 |
19 | 33890295 | rs34910385 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | NA | NA | chr19,33890001,33900000,chr19,33870001,33880000,25,Hi-C | NA | Evx2_2645,1.6285 | Fkh2-primary,1.37 | Gsh2_3990,2.2496 | Hoxa11_2218,2.0814 | Hoxa1_3425,1.6454 | NA | NA | NA | NA | NA | NA | 0.002 | 0.673 | 2.2 | R1 | T | NA | NA | NA | NA | NA | NA | NA | NA | Transcript |
19 | 33893008 | rs3786897 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | TFP.CTCF | NA | chr19,33890001,33900000,chr19,33870001,33880000,25,Hi-C | NA | Bas1-primary,1.4193 | Crx_3485,1.6214 | Nrg1-primary,2.2428 | Nrg1-primary,1.2934 | Six1_0935,2.673 | NA | NA | NA | NA | NA | NA | 0.015 | 0.841 | 0.546 | TF0 | G | NA | NA | NA | NA | NA | NA | NA | NA | Transcript |
19 | 33897478 | rs3786901 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | TFP.MYC | TFP.CTCF | MCV-5 | NA | chr19,33890001,33900000,chr19,33870001,33880000,25,Hi-C | NA | Asg1-DBD-primary,3.2615 | Cha4-primary,3.0278 | Gal4-primary,1.3114 | Hal9-primary,1.3637 | Hal9-primary,1.3637 | NA | NA | NA | NA | NA | NA | 0.002 | -0.211 | -1.58 | TF0 | C | NA | NA | NA | 0.460 | 0.430 | 0.340 | 0.650 |
19 | 33899065 | rs731839 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | NA | NA | chr19,33890001,33900000,chr19,33870001,33880000,25,Hi-C | NA | Cphx_3484,1.8527 | Cutl1_3494,7.7613 | Fkh1-FL-primary,1.5115 | Fkh1-FL-primary,1.3756 | Gat4-primary,3.6774 | NA | NA | NA | NA | NA | NA | 0.000 | -0.379 | -1.73 | R5 | A | NA | NA | NA | 0.590 | 0.450 | 0.610 | 0.640 | 0.660 | Transcript |
19 | 33906123 | rs4805885 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | NA | NA | chr19,33900001,33910000,chr19,33720001,33730000,6,Hi-C | NA | LM35,6.4881 | LM70,4.7552 | LM70,4.6808 | LM129,1.3916 | LM129,11.4694 | NA | NA | NA | NA | NA | NA | 0.000 | -2.043 | -5.23 | R5 | C | NA | NA | NA | NA | NA | NA | NA | NA | Transcript |
19 | 33909710 | rs8182584 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | MCV-2 | DRM | NA | chr19,33900001,33910000,chr19,33720001,33730000,6,Hi-C | NA | Aft1-primary,6.4613 | Asg1-DBD-primary,14.8516 | Met32-primary,2.074 | Pbf2-primary,2.4509 | Pbf2-primary,46.26 | NA | NA | NA | NA | NA | NA | 0.000 | -1.330 | -4.46 | R3 | G | NA | NA | NA | NA | NA | NA | NA | NA |
19 | 33909851 | rs8182579 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | DRM | MCV-1 | NA | chr19,33900001,33910000,chr19,33720001,33730000,6,Hi-C | NA | Ecm22-primary,23.8976 | Leu3-primary,1.2658 | Oaf1-DBD-primary,3.0569 | Stp2-primary,1.5825 | Tbs1-primary,1.6251 | NA | NA | NA | NA | NA | NA | 0.000 | -1.169 | -3.67 | TF0 | C | NA | NA | NA | NA | NA | NA | NA | NA |
19 | 33914285 | rs10500265 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | NA | NA | chr19,33910001,33920000,chr19,33930001,33940000,29,Hi-C | chr19,33910001,33920000,chr19,33720001,33730000,7,Hi-C | chr19,33910001,33920000,chr19,33340001,33350000,9,Hi-C | NA | Bas1-primary,1.5347 | Cbf1-primary,2.3192 | Cbf1-primary,1.9792 | Ceh-22,2.2853 | Nkx2-4_3074,2.8313 | NA | NA | NA | NA | NA | NA | 0.001 | 0.400 | 1.1 | TF1 | C | NA | NA | NA | NA | NA | NA | NA |
19 | 33914944 | rs4362488 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | NA | NA | chr19,33910001,33920000,chr19,33930001,33940000,29,Hi-C | chr19,33910001,33920000,chr19,33720001,33730000,7,Hi-C | chr19,33910001,33920000,chr19,33340001,33350000,9,Hi-C | NA | LM7,7.5128 | LM23,21.5245 | LM154,1.9742 | Broad-complex_3,22.7955 | Pax5,4.042 | NA | NA | NA | NA | NA | NA | 0.000 | -0.366 | -1.91 | R2 | G | NA | NA | NA | NA | NA | NA | NA |
19 | 33930229 | rs11670528 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | MCV-6 | NA | chr19,33930001,33940000,chr20,2970001,2980000,26,Hi-C | chr19,33930001,33940000,chr19,33910001,33920000,29,Hi-C | chr19,33930001,33940000,chr19,35270001,35280000,5,Hi-C | chr19,33930001,33940000,chr2,67810001,67820000,7,Hi-C | chr19,33930001,33940000,chr19,33720001,33730000,6,Hi-C | chr19,33930001,33940000,chr18,4220001,4230000,8,Hi-C | NA | LM4,2.2039 | LM4,1.5992 | LM9,1.5443 | LM133,7.5226 | LM138,3.6381 | NA | NA | NA | NA | NA | NA | 0.114 | 1.526 | 2.18 | TF0 | G | NA | NA | NA | NA |
19 | 33946893 | rs1477336 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | NA | NA | chr19,33940001,33950000,chr10,135380001,135390000,5,Hi-C | chr19,33940001,33950000,chr16,50620001,50630000,10,Hi-C | NA | Asg1-DBD-primary,1.8059 | Tye7-primary,1.2858 | Tye7-primary,1.4225 | LM155,3.2051 | LM204,5.3583 | NA | NA | NA | NA | NA | NA | 0.000 | -0.489 | -2.53 | R3 | C | NA | NA | NA | NA | NA | NA | NA | NA |
19 | 33950277 | rs17761012 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | MCV-1 | NA | NA | NA | LM106,38.3963 | LM106,2.0291 | LM156,16.7428 | GGAMTNNNNNTCCY,1.6379 | GAANYNYGACNY,1.4609 | NA | NA | NA | NA | NA | NA | 0.999 | 0.217 | 1.62 | L1 | C | NA | NA | NA | NA | NA | NA | NA | NA | Transcript |
19 | 33989245 | rs33825 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | MCV-1 | NA | chr19,33980001,33990000,chr1,150500001,150510000,4,Hi-C | chr19,33980001,33990000,chr19,33630001,33640000,8,Hi-C | NA | Dmbx1_2277,2.1132 | Evx2_2645,1.6189 | Leu3-primary,92.6126 | Pou6f1_1731,7.4019 | Pou6f1_3733,12.8688 | NA | NA | NA | NA | NA | NA | 0.000 | -0.424 | -1.56 | R3 | G | NA | NA | NA | 0.150 | 0.300 | 0.080 | 0.030 | 0.150 |
19 | 33990439 | rs33824 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | NA | NA | chr19,33990001,34000000,chr19,37600001,37610000,37,Hi-C | chr19,33990001,34000000,chr12,124940001,124950000,9,Hi-C | NA | Aft1-primary,2.3593 | Aro80-primary,1.4486 | Mig2-primary,2.5234 | Put3-primary,2.3229 | Tec1-primary,11.3963 | NA | NA | NA | NA | NA | NA | 0.000 | -2.916 | -4.57 | TF0 | T | NA | NA | NA | NA | NA | NA | NA | NA |
19 | 34000725 | rs33823 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | TFP.MYC | NA | chr19,34000001,34010000,chr19,34020001,34030000,30,Hi-C | chr19,34000001,34010000,chr19,22310001,22320000,5,Hi-C | chr19,34000001,34010000,chr4,32520001,32530000,6,Hi-C | chr19,34000001,34010000,chr8,21490001,21500000,11,Hi-C | chr19,34000001,34010000,chr4,33790001,33800000,6,Hi-C | NA | Gal4-primary,1.3118 | Gal4-primary,1.5488 | Gal4-primary,32.5484 | Gal4-primary,34.162 | Gzf3-primary,1.4441 | NA | NA | NA | NA | NA | NA | 0.005 | -0.174 | -0.542 | TF2 | T | NA | NA | NA | NA | NA |
19 | 34006380 | rs3786922 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | MCV-17 | NA | chr19,34000001,34010000,chr19,34020001,34030000,30,Hi-C | chr19,34000001,34010000,chr19,22310001,22320000,5,Hi-C | chr19,34000001,34010000,chr4,32520001,32530000,6,Hi-C | chr19,34000001,34010000,chr8,21490001,21500000,11,Hi-C | chr19,34000001,34010000,chr4,33790001,33800000,6,Hi-C | NA | LM156,9.174 | GGCNRNWCTTYS,1.8872 | HNF-3beta,1.3482 | Pax-5,1.5682 | XFD-1,1.6225 | NA | NA | NA | NA | NA | NA | 0.000 | -0.318 | -1.65 | R5 | T | NA | NA | NA | NA | NA |
19 | 34009392 | rs153508 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | NA | NA | chr19,34000001,34010000,chr19,34020001,34030000,30,Hi-C | chr19,34000001,34010000,chr19,22310001,22320000,5,Hi-C | chr19,34000001,34010000,chr4,32520001,32530000,6,Hi-C | chr19,34000001,34010000,chr8,21490001,21500000,11,Hi-C | chr19,34000001,34010000,chr4,33790001,33800000,6,Hi-C | NA | Aft1-primary,1.3693 | Asg1-DBD-primary,1.7764 | Mbp1-primary,29.1682 | Nrg1-primary,1.3007 | PFF0200c,3.2211 | NA | NA | NA | NA | NA | NA | 0.013 | 1.136 | 2.68 | TF0 | C | NA | NA | NA | NA | NA |
19 | 34010189 | rs10415555 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | MCV-2 | NA | NA | NA | LM67,1.7616 | LM115,8.3116 | LM147,3.0736 | LM179,5.1917 | Staf,1.5604 | NA | NA | NA | NA | NA | NA | 0.000 | -0.080 | -0.157 | L1 | A | NA | NA | NA | NA | NA | NA | NA | NA | Transcript |
19 | 34010289 | rs33840 | NM_000285,PEPD | NM_001166056,PEPD | NM_001166057,PEPD | ENST00000244137,ENSG00000124299 | ENST00000436370,ENSG00000124299 | ENST00000397032,ENSG00000124299 | MCV-2 | NA | NA | NA | LM2,2.6653 | LM7,1.8039 | LM30,1.5407 | LM82,1.3407 | LM89,2.2824 | NA | NA | NA | NA | NA | NA | 0.000 | -2.853 | -6.52 | TF0 | C | NA | NA | NA | NA | NA | NA | NA | NA | Transcript |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:25) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0000670 | Carious teeth | MP:0004033 | supernumerary teeth | occurrence of more than the usual number of teeth |
HP:0006528 | Chronic lung disease | MP:0010895 | increased lung compliance | increased ability of the lung to distend in response to pressure without disruption, usually expressed as the unit volume of change in the lung per unit of pressure |
HP:0000457 | Depressed nasal ridge | MP:0004872 | absent nasal septum | absence of the structure that separates the two nasal cavities |
HP:0003272 | Abnormality of the hip bone | MP:0009536 | abnormal interstitial cell of Cajal morphology | any structural anomaly in the type of cell found in the gastrointestinal tract and serving as a pacemaker that triggers gut contraction; ICCs mediate inputs from the enteric nervous system to smooth muscle cells and are thought to be the cells from which |
HP:0003196 | Short nose | MP:0002233 | abnormal nose morphology | any structural anomaly of the organ that is specialized for smell and is part of the respiratory system |
HP:0005280 | Depressed nasal bridge | MP:0013582 | abnormal lateral nasal gland morphology | any structural anomaly of the lateral nasal glands (the largest nasal secretory glands in rodents) which surround the maxillary sinus located in the lateral wall adjacent to each nasal passage and are characterized by cytologic features similar to those d |
HP:0002725 | Systemic lupus erythematosus | MP:0004801 | increased susceptibility to systemic lupus erythematosus | greater likelihood that an organism will develop inflammatory connective tissue symptoms characteristic of lupus including skin rash, arthritis and inflammation of different organs |
HP:0002715 | Abnormality of the immune system | MP:0009403 | increased variability of skeletal muscle fiber size | greater range or dispersion within a distribution of skeletal muscle fiber size within a muscle compared to controls |
HP:0002205 | Recurrent respiratory infections | MP:0014182 | decreased respiratory epithelial sodium ion transmembrane transport | decrease in the directed movement of sodium ions from one side of the respiratory epithelial cell membrane to the other |
HP:0001999 | Abnormal facial shape | MP:0008018 | increased facial tumor incidence | greater than the expected number of neoplasms on the face, usually in the form of a distinct mass, in a specific population in a given time period |
HP:0000992 | Cutaneous photosensitivity | MP:0001202 | skin photosensitivity | abnormally heightened reactivity of the skin to sunlight |
HP:0001263 | Global developmental delay | MP:0002084 | abnormal developmental patterning | abnormal systematic arrangement of the developing body along an axis |
HP:0000294 | Low anterior hairline | MP:0004784 | abnormal anterior cardinal vein morphology | any structural anomaly of the two paired veins draining the cephalic part of the body |
HP:0000958 | Dry skin | MP:0010678 | abnormal skin adnexa morphology | any structural anomaly of the tissue or structures associated with or embedded in the skin such as hair and hair follicles, sweat glands, sebaceous glands and claws or nails |
HP:0007703 | Abnormality of retinal pigmentation | MP:0011665 | d-loop transposition of the great arteries | complete transposition of the great arteries; the d- refers to the dextroposition of the bulboventricular loop (ie, the position of the right ventricle, which is on the right side); in addition, the aorta also tends to be on the right and anterior, and th |
HP:0000370 | Abnormality of the middle ear | MP:0010465 | aberrant origin of the right subclavian artery | the right subclavian artery arises from an atypical location on the aortic arch or the proximal descending aorta |
HP:0000963 | Thin skin | MP:0010678 | abnormal skin adnexa morphology | any structural anomaly of the tissue or structures associated with or embedded in the skin such as hair and hair follicles, sweat glands, sebaceous glands and claws or nails |
HP:0008065 | Aplasia/Hypoplasia of the skin | MP:0012069 | abnormal horizontal basal cell of olfactory epithelium morphology | any structural anomaly of the flat or angular epithelial cell with condensed nuclei and darkly staining cytoplasm containing numerous intermediate filaments inserted into desmosomes contacting surrounding supporting cells, that lie in contact with the bas |
HP:0001231 | Abnormality of the fingernails | MP:0012069 | abnormal horizontal basal cell of olfactory epithelium morphology | any structural anomaly of the flat or angular epithelial cell with condensed nuclei and darkly staining cytoplasm containing numerous intermediate filaments inserted into desmosomes contacting surrounding supporting cells, that lie in contact with the bas |
HP:0004349 | Reduced bone mineral density | MP:0013630 | increased bone trabecular spacing | increase in the amount of space between trabeculae in cancellous bone |
HP:0006532 | Recurrent pneumonia | MP:0001862 | interstitial pneumonia | any of a group of inflammatory and fibrotic disorders of the lower respiratory tract, primarily affecting the supporting framework of the lung, including the alveolar wall, but may also involve the small airways and blood vessels of the lung parenchyma |
HP:0006579 | Prolonged neonatal jaundice | MP:0011087 | neonatal lethality, complete penetrance | death of all organisms of a given genotype in a population within the neonatal period after birth (Mus: P0) |
HP:0000444 | Convex nasal ridge | MP:0004471 | short nasal bone | reduced length of either of two rectangular bone plates forming the bridge of the nose |
HP:0010669 | Hypoplasia of the zygomatic bone | MP:0011205 | excessive folding of visceral yolk sac | the appearance of wrinkles or folds on the surface of the visceral yolk sac |
HP:0001939 | Abnormality of metabolism/homeostasis | MP:0020010 | decreased bone mineral density of femur | reduction in the quatitative measurment value of mineral content of bone in the long bone of the thigh |
Mapped by homologous gene(Total Items:54) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0007598 | Bilateral single transverse palmar creases | MP:0012279 | wide sternum | an increase in the width of the long flat bone of the chest that articulates with the clavicle and first seven rib pairs |
HP:0002162 | Low posterior hairline | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0001007 | Hirsutism | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000508 | Ptosis | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0010783 | Erythema | MP:0013781 | abnormal mammary gland luminal epithelium morphology | any structural anomaly of the inner cell layer of the mammary epithelium bilayer that lines the luminal surface of mammary gland ducts and alveoli; luminal cells have only limited contact with the underlying basement membrane and surrounding connective ti |
HP:0000370 | Abnormality of the middle ear | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0002205 | Recurrent respiratory infections | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0000982 | Palmoplantar keratoderma | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0002725 | Systemic lupus erythematosus | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0003196 | Short nose | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0002240 | Hepatomegaly | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0000347 | Micrognathia | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0001903 | Anemia | MP:0020316 | decreased vascular endothelial cell proliferation | decrease in the expansion rate of any vascular endothelial cell population by cell division |
HP:0001744 | Splenomegaly | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000316 | Hypertelorism | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0007473 | Crusting erythematous dermatitis | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000992 | Cutaneous photosensitivity | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0001231 | Abnormality of the fingernails | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0005280 | Depressed nasal bridge | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0002857 | Genu valgum | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0001873 | Thrombocytopenia | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0000967 | Petechiae | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000670 | Carious teeth | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0001999 | Abnormal facial shape | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0000457 | Depressed nasal ridge | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000444 | Convex nasal ridge | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0006532 | Recurrent pneumonia | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0002099 | Asthma | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0002230 | Generalized hirsutism | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0002211 | White forelock | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000963 | Thin skin | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0001263 | Global developmental delay | MP:3000003 | abnormal Ebner's gland morphology | any structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l |
HP:0000520 | Proptosis | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0001249 | Intellectual disability | MP:0020316 | decreased vascular endothelial cell proliferation | decrease in the expansion rate of any vascular endothelial cell population by cell division |
HP:0001939 | Abnormality of metabolism/homeostasis | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000365 | Hearing impairment | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0200042 | Skin ulcer | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0000962 | Hyperkeratosis | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0006528 | Chronic lung disease | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0011220 | Prominent forehead | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0000294 | Low anterior hairline | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0007703 | Abnormality of retinal pigmentation | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0200034 | Papule | MP:0013745 | abnormal eyelid margin morphology | any structural anomaly of the confluence of the mucosal surface of the conjunctiva, the edge of the orbicularis, and the cutaneous epithelium |
HP:0001166 | Arachnodactyly | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0006579 | Prolonged neonatal jaundice | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0007489 | Diffuse telangiectasia | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000958 | Dry skin | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000989 | Pruritus | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0008065 | Aplasia/Hypoplasia of the skin | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0004349 | Reduced bone mineral density | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0002715 | Abnormality of the immune system | MP:0014125 | decreased amylin secretion | reduction in the production or release of the polypeptide hormone that is normally co-secreted with insulin by the beta cells of the pancreatic islets of Langerhans and is known to inhibit glucagon secretion, delay gastric emptying, and act as a satiety a |
HP:0010669 | Hypoplasia of the zygomatic bone | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000505 | Visual impairment | MP:3000003 | abnormal Ebner's gland morphology | any structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l |
HP:0003272 | Abnormality of the hip bone | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
Disease ID | 239 |
---|---|
Disease | prolidase deficiency |
Case | (Waiting for update.) |